PRIME THERAPEUTICS for PRIME THERAPEUTICS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription drug abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 POlicy and Technical CHanges to the Medicare Advantage and Medicare Prescription Drug Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FAHRNER | — |
Health Issues HCR
Prescription Drug Abuse The Medicare Part D Patient Safety and Drug Abuse Prevention Act HR 3392, The Patients Access to Treatments Act of 2013 HR 460, The Medicare Prescription Drug Program Integrity and Transparency Act S. 867, The Preserving Our Hometown Independent Pharmacies Act (HR 1188), The Generic Drug Pricing Fairness Act of 2014 HE 4437 Final Rule Program Integrity: Exchange, SHOP, Premium Stabilization Programs, and Market Standards Proposed Rule - Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug benefit Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FAHRNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.